Pfizer's Rocky Mount Facility Restarts Production Amid First Phase Of Post-Tornado Recovery Efforts; Restarts Production Through Phased Approach, With Full Production Across Site's Three Manufacturing Suites Anticipated By End Of 2023
Portfolio Pulse from Benzinga Newsdesk
Pfizer has restarted production at its Rocky Mount facility as part of the first phase of recovery efforts following a tornado. The company plans to fully restore production across the site's three manufacturing suites by the end of 2023.
September 25, 2023 | 4:06 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Pfizer's recovery efforts at its Rocky Mount facility could potentially impact its production capabilities and financial performance in the short term.
The restart of production at Pfizer's Rocky Mount facility indicates progress in recovery efforts. However, full production is not expected until the end of 2023, which could potentially impact Pfizer's production capabilities and financial performance in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100